vs
Side-by-side financial comparison of C3.ai, Inc. (AI) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
C3.ai, Inc. is the larger business by last-quarter revenue ($75.1M vs $47.7M, roughly 1.6× IRONWOOD PHARMACEUTICALS INC). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -139.3%, a 134.5% gap on every dollar of revenue. On growth, C3.ai, Inc. posted the faster year-over-year revenue change (-20.3% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $-46.9M). Over the past eight quarters, C3.ai, Inc.'s revenue compounded faster (-2.1% CAGR vs -20.2%).
C3.ai, Inc. is a leading enterprise artificial intelligence software provider that develops and delivers scalable AI applications, platform tools, and industry-specific solutions for clients across sectors including manufacturing, energy, financial services, healthcare and public sector. Its offerings help organizations optimize operations, reduce costs, mitigate risks, and realize data-driven decision making.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
AI vs IRWD — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $47.7M |
| Net Profit | $-104.7M | $-2.3M |
| Gross Margin | 40.4% | — |
| Operating Margin | -149.2% | 14.3% |
| Net Margin | -139.3% | -4.8% |
| Revenue YoY | -20.3% | -47.3% |
| Net Profit YoY | -58.7% | -200.9% |
| EPS (diluted) | $-0.75 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $47.7M | ||
| Q3 25 | $70.3M | $122.1M | ||
| Q2 25 | $108.7M | $85.2M | ||
| Q1 25 | $98.8M | $41.1M | ||
| Q4 24 | $94.3M | $90.5M | ||
| Q3 24 | $87.2M | $91.6M | ||
| Q2 24 | $86.6M | $94.4M | ||
| Q1 24 | $78.4M | $74.9M |
| Q4 25 | $-104.7M | $-2.3M | ||
| Q3 25 | $-116.8M | $40.1M | ||
| Q2 25 | $-79.7M | $23.6M | ||
| Q1 25 | $-80.2M | $-37.4M | ||
| Q4 24 | $-66.0M | $2.3M | ||
| Q3 24 | $-62.8M | $3.6M | ||
| Q2 24 | $-72.9M | $-860.0K | ||
| Q1 24 | $-72.6M | $-4.2M |
| Q4 25 | 40.4% | — | ||
| Q3 25 | 37.6% | — | ||
| Q2 25 | 62.1% | — | ||
| Q1 25 | 59.1% | — | ||
| Q4 24 | 61.3% | — | ||
| Q3 24 | 59.8% | — | ||
| Q2 24 | 59.6% | — | ||
| Q1 24 | 57.8% | — |
| Q4 25 | -149.2% | 14.3% | ||
| Q3 25 | -177.7% | 61.8% | ||
| Q2 25 | -81.8% | 53.2% | ||
| Q1 25 | -88.7% | -70.7% | ||
| Q4 24 | -79.8% | 34.8% | ||
| Q3 24 | -83.2% | 28.0% | ||
| Q2 24 | -95.1% | 26.5% | ||
| Q1 24 | -105.3% | 14.7% |
| Q4 25 | -139.3% | -4.8% | ||
| Q3 25 | -166.2% | 32.8% | ||
| Q2 25 | -73.3% | 27.7% | ||
| Q1 25 | -81.2% | -90.9% | ||
| Q4 24 | -69.9% | 2.5% | ||
| Q3 24 | -72.0% | 4.0% | ||
| Q2 24 | -84.2% | -0.9% | ||
| Q1 24 | -92.6% | -5.6% |
| Q4 25 | $-0.75 | $0.01 | ||
| Q3 25 | $-0.86 | $0.23 | ||
| Q2 25 | $-0.60 | $0.14 | ||
| Q1 25 | $-0.62 | $-0.23 | ||
| Q4 24 | $-0.52 | $0.03 | ||
| Q3 24 | $-0.50 | $0.02 | ||
| Q2 24 | $-0.59 | $-0.01 | ||
| Q1 24 | $-0.60 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $675.0M | $215.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $771.9M | $-261.8M |
| Total Assets | $961.3M | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $675.0M | $215.5M | ||
| Q3 25 | $711.9M | $140.4M | ||
| Q2 25 | $742.7M | $92.9M | ||
| Q1 25 | $724.3M | $108.5M | ||
| Q4 24 | $730.4M | $88.6M | ||
| Q3 24 | $762.5M | $88.2M | ||
| Q2 24 | $750.4M | $105.5M | ||
| Q1 24 | $723.3M | $121.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $771.9M | $-261.8M | ||
| Q3 25 | $798.8M | $-264.2M | ||
| Q2 25 | $838.3M | $-308.2M | ||
| Q1 25 | $860.2M | $-334.1M | ||
| Q4 24 | $859.0M | $-301.3M | ||
| Q3 24 | $874.9M | $-311.3M | ||
| Q2 24 | $873.4M | $-321.7M | ||
| Q1 24 | $898.0M | $-330.5M |
| Q4 25 | $961.3M | $396.9M | ||
| Q3 25 | $968.7M | $396.1M | ||
| Q2 25 | $1.0B | $342.9M | ||
| Q1 25 | $1.1B | $327.2M | ||
| Q4 24 | $1.0B | $350.9M | ||
| Q3 24 | $1.1B | $389.5M | ||
| Q2 24 | $1.0B | $395.6M | ||
| Q1 24 | $1.1B | $438.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-46.5M | $74.6M |
| Free Cash FlowOCF − Capex | $-46.9M | $74.6M |
| FCF MarginFCF / Revenue | -62.4% | 156.3% |
| Capex IntensityCapex / Revenue | 0.5% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-93.2M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-46.5M | $74.6M | ||
| Q3 25 | $-33.5M | $47.6M | ||
| Q2 25 | $11.3M | $-15.1M | ||
| Q1 25 | $-22.0M | $20.0M | ||
| Q4 24 | $-38.7M | $15.2M | ||
| Q3 24 | $8.0M | $9.9M | ||
| Q2 24 | $21.3M | $33.5M | ||
| Q1 24 | $-39.1M | $45.0M |
| Q4 25 | $-46.9M | $74.6M | ||
| Q3 25 | $-34.3M | $47.6M | ||
| Q2 25 | $10.3M | $-15.1M | ||
| Q1 25 | $-22.4M | $19.9M | ||
| Q4 24 | $-39.5M | — | ||
| Q3 24 | $7.1M | $9.9M | ||
| Q2 24 | $18.8M | $33.4M | ||
| Q1 24 | $-45.1M | $44.9M |
| Q4 25 | -62.4% | 156.3% | ||
| Q3 25 | -48.8% | 39.0% | ||
| Q2 25 | 9.5% | -17.7% | ||
| Q1 25 | -22.7% | 48.4% | ||
| Q4 24 | -41.9% | — | ||
| Q3 24 | 8.2% | 10.8% | ||
| Q2 24 | 21.7% | 35.4% | ||
| Q1 24 | -57.6% | 60.0% |
| Q4 25 | 0.5% | 0.0% | ||
| Q3 25 | 1.1% | 0.0% | ||
| Q2 25 | 0.9% | 0.0% | ||
| Q1 25 | 0.4% | 0.1% | ||
| Q4 24 | 0.9% | 0.0% | ||
| Q3 24 | 1.1% | 0.0% | ||
| Q2 24 | 2.9% | 0.1% | ||
| Q1 24 | 7.8% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AI
| License And Service | $70.2M | 93% |
| Professional Services | $4.9M | 7% |
IRWD
Segment breakdown not available.
